|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.84 CAD | -1.18% |
|
+2.44% | +1.20% |
| Jan. 29 | Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
| 2023 | Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Cannara Biotech Inc. reported earnings results for the fourth quarter ended August 31, 2023. For the fourth quarter, the company reported sales was CAD 18.14 million compared to CAD 11.89 million a year ago. Revenue was CAD 18.28 million compared to CAD 11.95 million a year ago.
Net income was CAD 4.63 million compared to CAD 2.55 million a year ago. Basic earnings per share from continuing operations was CAD 0.05. Diluted earnings per share from continuing operations was CAD 0.05.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.20% | 55.24M | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| -42.17% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
CANNARA BIOTECH INC. 
